House Panel May Subpoena FDA Investigators To Address Ketek Safety Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency foot-dragging over questions regarding approval of the Sanofi-Aventis antibiotic leads House Energy and Commerce subcommittee to consider forcing testimony.